Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-068562
Filing Date
2025-05-12
Accepted
2025-05-12 07:30:23
Documents
63
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mtsr-20250331.htm   iXBRL 10-Q 2739021
2 EX-19.1 mtsr-ex19_1.htm EX-19.1 45461
3 EX-31.1 mtsr-ex31_1.htm EX-31.1 17453
4 EX-31.2 mtsr-ex31_2.htm EX-31.2 17424
5 EX-32.1 mtsr-ex32_1.htm EX-32.1 10009
6 EX-32.2 mtsr-ex32_2.htm EX-32.2 9985
7 GRAPHIC img54167497_0.jpg GRAPHIC 433343
  Complete submission text file 0000950170-25-068562.txt   11093152

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mtsr-20250331.xsd EX-101.SCH 1327675
66 EXTRACTED XBRL INSTANCE DOCUMENT mtsr-20250331_htm.xml XML 1713444
Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Filer) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42489 | Film No.: 25932580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)